Bangkok--11 Dec--Weber Shandwick
(from left): Dr. Stefan Verlohren, Consultant Obstetrician and Gynaecologist and Foetal Medicine Specialist at the Charite University Medicine, Berlin, Germany and Dr. Vitaya Titapant, Associate Professor and previous chief at the division of Maternal Foetal Medicine, Department of Obstetrics and Gynaecology, Siriraj Hospital, Mahidol University have recently shared Thai media the information of preeclampsia in the topics of its background, local situation in Thailand / global updates, how it can create dangers to pregnant women and their unborn children, signs and symptoms of preeclampsia,the current methods of diagnosis and treatment and how innovative blood test allows doctors to predict which pregnant women are at highest risk of developing preeclampsia, one of the leading causes of death and complications for mothers and their unborn babies. Identifying women who are at risk means that close monitoring can be stepped up to protect the health and safety of both mother and baby. Furthermore, the test identifies women who are unlikely to develop the disease in the short–term, so saving them from the stress of monitoring and the disruption to their home life caused by a stay in hospital and removing at the same time, the cost of unnecessary care.